Recent studies on nitrates: Their action, bioactivation and development of tolerance;Neue erkenntnisse bei der nitratwirkung, nitratbioaktivierung und toleranzentwicklung

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 44, 2008, Pages 2277-2282

  Münzel, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Coronary heart disease; Drug tolerance; Nitrates; Nitric oxide; Nitroglycerin; Pentaerythretyl tetranitrate

Indexed keywords

GLYCERYL TRINITRATE; ISOSORBIDE; MOLSIDOMINE; NITRIC ACID DERIVATIVE; PENTAERYTHRITYL TETRANITRATE; ALDEHYDE DEHYDROGENASE; ALDH2 PROTEIN, HUMAN; DRUG DERIVATIVE; GUANYLATE CYCLASE; HYDRALAZINE; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE-5-MONONITRATE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; REACTIVE OXYGEN METABOLITE; VASODILATOR AGENT;

ANGINA PECTORIS; DRUG MECHANISM; DRUG TOLERANCE; HEMODYNAMICS; OXIDATIVE STRESS; REVIEW; VASODILATATION; CORONARY ARTERY DISEASE; DRUG EFFECT; HEART FAILURE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ALDEHYDE DEHYDROGENASE; CORONARY DISEASE; DRUG TOLERANCE; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; HEART FAILURE; HUMANS; HYDRALAZINE; ISOSORBIDE DINITRATE; MOLSIDOMINE; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGLYCERIN; OXIDATIVE STRESS; PENTAERYTHRITOL TETRANITRATE; REACTIVE OXYGEN SPECIES; VASODILATION; VASODILATOR AGENTS;

EID: 54849414292     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1091272     Document Type: Review

References (32)

1. Abrams J. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration. Drugs 1987; 34: 391-403
2. Anand IS, Tam SW, Rector TS et al. Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol 2007; 49: 32-39
3. Azevedo ER, Schofield AM, Kelly S, Parker JD. Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine. J Am Coll Cardiol 2001; 37: 505-509
4. Caramori PR, Adelman AG, Azevedo ER et al. Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine. J Am Coll Cardiol 1998; 32: 1969-1974
5. Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A 2002; 99: 8306-8311
6. Cohn JN, Archibald DC, Ziesche S et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. The New England journal of medicine 1986; 314: 1547-1552
7. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. The New England journal of medicine 1991; 325: 303-310
8. Daiber A, Oelze M, Coldewey M et al. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation forks beneficial effects on prognosis in patients with congestive heart failure. Biochem Biophys Res Commun 2005; 338: 1865-1874
9. Daiber A, Oelze M, Coldewey M et al. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 2004; 66: 1372-1382
10. Esplugues JV, Rocha M, Nunez C et al. Complex 1 dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ Res 2006; 99: 1067-1075
11. Franciosa JA Blank RC, Cohn JN. Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. Am J Med 1978; 64: 207-213
12. Franciosa JA, Cohn JN. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure. Am J Med 1978; 65: 126-133
13. Gogia H, Mehra A, Parikh S et al. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J Am Coll Cardiol 1995; 26: 1575-1580
14. Gori T, Burstein JM, Ahmed S et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 2001; 104: 1119-1123
15. Gori T, Mak SS, Kelly S, Parker JD. Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J Am Coll Cardiol 2001; 38: 1096-1101
16. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678
17. Hink U, Oelze M, Kolb P et al. Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. J Am Coll Cardiol 2003; 42: 1826-1834
18. Jurt U, Gori T, Ravandi A et al. Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol 2001; 38: 854-859
19. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 2003; 278: 22546-22554
20. Munzel T, Daiber A, Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res 2005; 97: 618-628
21. Munzel T, Feil R, Mulsch A et al. Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase [corrected]. Circulation 2003; 108: 2172-2183
22. Munzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci U S A 1995; 92: 5244-5248
23. Munzel T, Heitzer T, Kurz S et al. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. J Am Coll Cardiol 1996; 27: 297-303
24. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995; 95: 187-194
25. Oberle S, Abate A, Grosser N et al. Endothelial protection by pentaerithrityl trinitrate: bilirubin and carbon monoxide as possible mediators. Exp Biol Med (Maywood) 2003; 228: 529-534
26. Pfeifer A, Klatt P, Massberg S et al. Defective smooth muscle regulation in cGMP kinase I-deficient mice. Embo J 1998; 17: 3045-3051
27. Silber S. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate. Eur J Clin Pharmacol 1990; 38 Suppl 1: S35-51
28. Taylor AL, Ziesche S, Yancy C et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. The New England journal of medicine 2004; 351: 2049-2057
29. Thomas GR, DiFabio JM, Gori T, Parker JD. Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J Am Coll Cardiol 2007; 49: 1289-1295
30. Thum T, Fraccarollo D, Thum S, Schultheiss M, Daiber A, Wenzel P, Munzel T, Ertl G, Bauersachs J. Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. Arterioscler Thromb Vasc Biol. 2007; 27: 748-754
31. Wenzel P, Hink U, Oelze M et al. Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice. Br J Pharmacol 2007; 150: 526-533
32. Wenzel P, Oelze M, Coldewey M et al. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler Thromb Vasc Biol 2007; 27: 1729-1735